Company seeks strategic partners to advance novel PlaCCine technology LAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq:…
Company seeks strategic partners to advance novel PlaCCine technology
LAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapies and evalua… [5908 chars]
Source: GlobeNewswire | Published: 2025-10-17T00:00:00Z
Credit: GlobeNewswire
